-
CF Lung Infection Therapy AR-501 Granted FDA Orphan Drug Status
Aridis Pharmaceuticals’ AR-501, an inhaled formulation of gallium citrate for chronic lung infections, was granted the FDA’s orphan drug status. Read more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.